Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments
  • USA - English


News provided by

Parker Waichman LLP

Aug 27, 2014, 15:45 ET

Share this article

Share toX

Share this article

Share toX


Port Washington, New York (PRWEB) August 27, 2014 -- Parker Waichman LLP, a national law firm long dedicated to protecting the rights of victims injured by defective medical devices, reports that the Court has put new rules in place for discovery procedures, specifically Collection and Preservation of Evidence, in a multidistrict litigation (MDL) brought over C.R. Bard’s transvaginal mesh devices. (MDL No. 2187, In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation, the United States District Court, Southern District or West Virginia; Honorable Joseph R. Goodwin)

“We represent many women who have filed lawsuits over alleged injuries associated with transvaginal mesh and continue to provide free legal advice for anyone who seeks more information about their rights,” Mr. Falkowitz noted.

Post this

The new rules provide that “discovery in this proceeding may involve the collection, division, storage, preservation, and production of biomaterials evidence for which special handling, division, storage, and preservation would be warranted,” the Court indicated. The Evidence Protocol Order—Pretrial Order #136—was filed on August 18, 2014 in the MDL court that oversees the C.R. Bard litigation (In re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation; Case 2:10-md-02187, U.S. District Court for the Southern District of West Virginia, Charleston Division).

“The Court’s Order indicates that the litigation continues to move forward and in a more efficient manner,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP. “The continuing progression of the transvaginal mesh device claims should help bring injured women closer to receiving the compensation they deserve,” Mr. Falkowitz added.

The Order, dated July 30, 2014, followed a stipulation requested by the parties to the MDL in which the Court was petitioned to enter an “evidence preservation protocol order,” for existing and future actions in the litigation. The stated intent is “that all Material that has not previously been analyzed or tested ... be preserved in a manner that permits the Parties equal access to, and analysis of, the Material. The Parties will not interfere with or circumvent the analysis and preservation of Materials by the Facilities to which any of Plaintiffs’ treating physicians have sent or will send the Materials in the usual course of business.” (MDL No. 2187, In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation, the United States District Court, Southern District or West Virginia; Honorable Joseph R. Goodwin)

Once the pre-trial proceedings, which are detailed in the Order, have been completed, the Court will transfer the cases which had been directly filed back to the appropriate federal district; the lawsuits brought over the C.R. Bard vaginal mesh that were organized by the U.S. Judicial Panel on MDLs in the Southern District of West Virginia will be remanded to their originally filed federal districts. (In re C.R. Bard Inc. Pelvic Repair System Products Liability Litigation, MDL No. 2187)

Meanwhile, according to a June 30, 2014 Securities Exchange Commission (SEC) filing, C.R. Bard, agreed to a settlement of more than 500 of the Avaulta transvaginal mesh lawsuits that were pending against the firm. A settlement amount was not disclosed at the time of the SEC filing. In addition to these cases, the device maker faces thousands of lawsuits nationwide. Most were consolidated as part of the federal MDL centralized before U.S. District Judge Joseph Goodwin in the Southern District of West Virginia. Nearly 60,000 federally filed MDLs involving transvaginal mesh, including more than 9,000 filed against C.R. Bard, were brought against an array of transvaginal device makers and are pending. The cases are:

• In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2325)
• In re: Boston Scientific Corp., Pelvic Repair System Products Liability Litigation (MDL No. 2326)
• In re: Coloplast Corp. Pelvic Support System Products Liability Litigation (MDL No. 2387)
• In re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation (MDL No. 2440)
• In re: C.R. Bard Inc. Pelvic Repair System Products Liability Litigation (MDL No. 2187)
• In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation (MDL No. 2327)
• In re: Neomedic Pelvic Repair System Products Liability Litigation (MDL 2511)

The lawsuits brought against C.R. Bard over its Avaulta transvaginal mesh, as well as actions brought against other transvaginal mesh manufacturers, all similarly allege significant injuries following surgery that utilized vaginal mesh to repair pelvic organ prolapse (POP) or stress urinary incontinence (SUI) in women. These women also similarly allege that the devices are defective and provide an unnecessary risk of injury, according to Parker Waichman LLP, which has filed a number of lawsuits in the various MDLs being overseen by Judge Goodwin, including against Johnson & Johnson, the parent company of Ethicon; AMS; and Boston Scientific.

“We represent many women who have filed lawsuits over alleged injuries associated with transvaginal mesh and continue to provide free legal advice for anyone who seeks more information about their rights,” Mr. Falkowitz noted.

Parker Waichman LLP continues to offer free lawsuit consultations to victims of transvaginal mesh, pelvic mesh, and vaginal implant injuries. If you or a loved one experienced complications following mesh-related surgery for pelvic organ prolapse (POP) or stress urinary incontinence (SUI), please visit the firm's transvaginal mesh injury page at yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Gary Falkowitz, Parker Waichman LLP, http://yourlawyer.com, +1 (800) 529-4636, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.